Related Content
Search Google Scholar for:
|
|
Science 8 April 1988: Vol. 240. no. 4849, pp. 196 - 199 DOI: 10.1126/science.2895499
|
|
Articles
Science, Vol 240, Issue 4849, 196-199
Copyright © 1988 by American Association for the Advancement of Science
Absence of TGF-beta receptors and growth inhibitory responses in retinoblastoma cells
A Kimchi,
XF Wang,
RA Weinberg,
S Cheifetz,
and
J Massague
Department of Virology, Weizmann Institute of Science, Rehovot, Israel.
The responses of retinoblastoma tumor cells and normal retinal cells to various growth inhibitory factors were examined. Whereas fetal retinal cells were highly sensitive to the antimitogenic effects of transforming growth factor beta 1 (TGF-beta 1), retinoblastoma tumor cell lines were all resistant to this factor. Binding assays and affinity labeling of these cells with radioiodinated TGF-beta 1 revealed that the cells did not have TGF-beta receptors. The retinoblastoma cells lacked the three affinity-labeled proteins of 65, 95, and 300 kilodaltons typically seen in human cell lines and thus differed from normal retinal cells and from other types of neuroectodermal tumors that display the normal pattern of receptors. Loss of TGF-beta receptors, which is a rare event among tumor cells, may represent one mechanism through which these cells escape from negative control and form retinoblastomas.
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
- SMAD6 Contributes to Patient Survival in Non-Small Cell Lung Cancer and Its Knockdown Reestablishes TGF-{beta} Homeostasis in Lung Cancer Cells.
- H.-S. Jeon, T. Dracheva, S.-H. Yang, D. Meerzaman, J. Fukuoka, A. Shakoori, K. Shilo, W. D. Travis, and J. Jen (2008)
Cancer Res.
68, 9686-9692
| Abstract »
| Full Text »
| PDF »
- Transforming growth factor-{beta} signaling and ubiquitinators in cancer.
- E. Glasgow and L. Mishra (2008)
Endocr. Relat. Cancer
15, 59-72
| Abstract »
| Full Text »
| PDF »
- Transforming Growth Factor-{beta} Pathway Serves as a Primary Tumor Suppressor in CD8+ T Cell Tumorigenesis.
- P. J. Lucas, N. McNeil, E. Hilgenfeld, B. Choudhury, S.-J. Kim, M. A. Eckhaus, T. Ried, and R. E. Gress (2004)
Cancer Res.
64, 6524-6529
| Abstract »
| Full Text »
| PDF »
- PMEPA1, a Transforming Growth Factor-{beta}-induced Marker of Terminal Colonocyte Differentiation Whose Expression Is Maintained in Primary and Metastatic Colon Cancer.
- E. B. Brunschwig, K. Wilson, D. Mack, D. Dawson, E. Lawrence, J. K.V. Willson, S. Lu, A. Nosrati, R. M. Rerko, S. Swinler, et al. (2003)
Cancer Res.
63, 1568-1575
| Abstract »
| Full Text »
| PDF »
- Disruption of Transforming Growth Factor {beta} Signaling by a Novel Ligand-dependent Mechanism.
- T. Fernandez, S. Amoroso, S. Sharpe, G. M. Jones, V. Bliskovski, A. Kovalchuk, L. M. Wakefield, S.-J. Kim, M. Potter, and J. J. Letterio (2002)
J. Exp. Med.
195, 1247-1255
| Abstract »
| Full Text »
| PDF »
- Vascular Endothelial Cell Growth Factors Promote the In Vitro Development of Rat Photoreceptor Cells.
- P. A. Yourey, S. Gohari, J. L. Su, and R. F. Alderson (2000)
J. Neurosci.
20, 6781-6788
| Abstract »
| Full Text »
| PDF »
- Transforming growth factor-beta : pleiotropic role in the regulation of hematopoiesis.
- N. O. Fortunel, A. Hatzfeld, and J. A. Hatzfeld (2000)
Blood
96, 2022-2036
| Abstract »
| Full Text »
| PDF »
- Release from Quiescence of Primitive Human Hematopoietic Stem/Progenitor Cells by Blocking Their Cell-Surface TGF-{beta} Type II Receptor in a Short-Term In Vitro Assay.
- N. Fortunel, J. Hatzfeld, S. Kisselev, M.-N. Monier, K. Ducos, A. Cardoso, P. Batard, and A. Hatzfeld (2000)
Stem Cells
18, 102-111
| Abstract »
| Full Text »
- A Deletion in the Gene for Transforming Growth Factor beta Type I Receptor Abolishes Growth Regulation by Transforming Growth Factor beta in a Cutaneous T-Cell Lymphoma.
- W. P. Schiemann, W. M. Pfeifer, E. Levi, M. E. Kadin, and H. F. Lodish (1999)
Blood
94, 2854-2861
| Abstract »
| Full Text »
| PDF »
- p53-Independent Role of MDM2 in TGF-1 Resistance.
- P. Sun, P. Dong, K. Dai, G. J. Hannon, and D. Beach (1998)
Science
282, 2270-2272
| Abstract »
| Full Text »
- High proliferative potential-quiescent cells: a working model to study primitive quiescent hematopoietic cells.
- N Fortunel, P Batard, A Hatzfeld, M. Monier, B Panterne, J Lebkowski, and J Hatzfeld (1998)
J. Cell Sci.
111, 1867-1875
| Abstract »
| PDF »
- Consistent loss of functional transforming growth factor beta receptor expression in murine plasmacytomas.
- S. R. Amoroso, N. Huang, A. B. Roberts, M. Potter, and J. J. Letterio (1998)
PNAS
95, 189-194
| Abstract »
| Full Text »
| PDF »
- Expression of Transforming Growth Factor beta Type III Receptor Suppresses Tumorigenicity of Human Breast Cancer MDA-MB-231 Cells.
- L. Sun and C. Chen (1997)
J. Biol. Chem.
272, 25367-25372
| Abstract »
| Full Text »
| PDF »
- Loss of functional cell surface transforming growth factor beta (TGF-beta ) type 1 receptor correlates with insensitivity to TGF-beta in chronic lymphocytic leukemia.
- J. F. DeCoteau, P. I. Knaus, H. Yankelev, M. D. Reis, R. Lowsky, H. F. Lodish, and M. E. Kadin (1997)
PNAS
94, 5877-5881
| Abstract »
| Full Text »
| PDF »
- Expression of Transforming Growth Factor beta (TGFbeta ) Type III Receptor Restores Autocrine TGFbeta 1 Activity in Human Breast Cancer MCF-7 Cells.
- C. Chen, X.-F. Wang, and L. Sun (1997)
J. Biol. Chem.
272, 12862-12867
| Abstract »
| Full Text »
| PDF »
- The Role of Transforming Growth Factor-{beta} in the Regulation of Estrogen Receptor Expression in the MCF-7 Breast Cancer Cell Line.
- A. Stoica, M. Saceda, A. Fakhro, H. B. Solomon, B. D. Fenster, and M. B. Martin (1997)
Endocrinology
138, 1498-1505
| Abstract »
| Full Text »
| PDF »
- Mechanism of E1A-Induced Transforming Growth Factor-beta (TGF-beta ) Resistance in Mouse Keratinocytes Involves Repression of TGF-beta Type II Receptor Transcription.
- D. H. Kim, J. H. Chang, K. H. Lee, H.-Y. Lee, and S.-J. Kim (1997)
J. Biol. Chem.
272, 688-694
| Abstract »
| Full Text »
| PDF »
- Reduced Expression of Transforming Growth Factor beta Type I Receptor Contributes to the Malignancy of Human Colon Carcinoma Cells.
- J. Wang, W. Han, E. Zborowska, J. Liang, X. Wang, J. K.V. Willson, L. Sun, and M. G. Brattain (1996)
J. Biol. Chem.
271, 17366-17371
| Abstract »
| Full Text »
| PDF »
- Characterization of the Promoter Region of the Human Transforming Growth Factor-beta Type II Receptor Gene.
- H. W. Bae, A. G. Geiser, D. H. Kim, M. T. Chung, J. K. Burmester, M. B. Sporn, A. B. Roberts, and S.-J. Kim (1995)
J. Biol. Chem.
270, 29460-29468
| Abstract »
| Full Text »
| PDF »
- Demonstration That Mutation of the Type II Transforming Growth Factor beta Receptor Inactivates Its Tumor Suppressor Activity in Replication Error-positive Colon Carcinoma Cells.
- J. Wang, L. Sun, L. Myeroff, X. Wang, L. E. Gentry, J. Yang, J. Liang, E. Zborowska, S. Markowitz, J. K. V. Willson, et al. (1995)
J. Biol. Chem.
270, 22044-22049
| Abstract »
| Full Text »
| PDF »
- Inhibition of Capillary Morphogenesis and Associated Apoptosis by Dominant Negative Mutant Transforming Growth Factor-beta Receptors.
- M. E. Choi and B. J. Ballermann (1995)
J. Biol. Chem.
270, 21144-21150
| Abstract »
| Full Text »
| PDF »
- Inactive Type II and Type I Receptors for TGFbeta Are Dominant Inhibitors of TGFbeta-dependent Transcription.
- T. Brand and M. D. Schneider (1995)
J. Biol. Chem.
270, 8274-8284
| Abstract »
| Full Text »
| PDF »
- Inactivation of the type II receptor reveals two receptor pathways for the diverse TGF-beta activities.
- R. Chen, R Ebner, and R Derynck (1993)
Science
260, 1335-1338
| Abstract »
| PDF »
- c-myc and pRB: Role in TGF-{beta}1 Inhibition of Keratinocyte Proliferation.
- C.S. Murphy, J.A. Pietenpol, K. Munger, P.M. Howley, and H.L. Moses (1991)
Cold Spring Harb Symp Quant Biol
56, 129-135
| Abstract »
| PDF »
- Anti-oncogenes and the Negative Regulation of Cell Growth.
- J.M. Horowitz, S.H. Friend, R.A. Weinberg, P. Whyte, K. Buchkovich, and E. Harlow (1988)
Cold Spring Harb Symp Quant Biol
53, 843-847
| Abstract »
| PDF »
|
|